2-amino-3-chloro-1,4-naphthoquinone and Optic Atrophy, Hereditary, Leber

2-amino-3-chloro-1,4-naphthoquinone has been researched along with Optic Atrophy, Hereditary, Leber in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aeschlimann, P; Beirne, K; Brancale, A; Heard, C; Rozanowska, M; Varricchio, C; Votruba, M	1

Other Studies

1 other study(ies) available for 2-amino-3-chloro-1,4-naphthoquinone and Optic Atrophy, Hereditary, Leber

Article	Year
Discovery of Novel 2-Aniline-1,4-naphthoquinones as Potential New Drug Treatment for Leber's Hereditary Optic Neuropathy (LHON). Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22 Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Female; Hep G2 Cells; Humans; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Optic Atrophy, Hereditary, Leber; Pharmaceutical Preparations; Treatment Outcome	2020

Article

Year

Discovery of Novel 2-Aniline-1,4-naphthoquinones as Potential New Drug Treatment for Leber's Hereditary Optic Neuropathy (LHON).

Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22

Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Female; Hep G2 Cells; Humans; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Optic Atrophy, Hereditary, Leber; Pharmaceutical Preparations; Treatment Outcome

2020